Analytik Jena AG (Frankfurt DE0005213508, Prime Standard: AJA) expects sales for the current financial year 2012/2013 to exceed EUR 100.0 m for the first time in the Company's history.
This was announced today by the manufacturer of analytical instrumentation, life science instruments and optoelectronics in the run-up to its Annual General Meeting in Jena, where the Company is headquartered. In the previous financial year, Analytik Jena had generated consolidated sales of EUR 94.0 m.
The Company also expects a stable development of earnings and thus expects to continue to increase earnings before interest, taxes, depreciation and amortization (EBITDA) with an EBITDA margin of more than 10.0 % and to achieve an operating profit (EBIT) above EUR 6.0 m or at previous year's level, respectively. EBITDA amounted to EUR 10.2 m with an EBITDA margin of 10.8 % in the previous year. Analytik Jena expects earnings per share (EPS) to decrease due to the unfavorable exchange rate situation in comparison to the previous year. Analytik Jena generated an operating profit of EUR 6.1 m in the previous year. Both basic and diluted earnings per share amounted to EUR 0.59 in financial year 2011/2012.
In the first half of the financial year 2012/2013 Analytik Jena generated consolidated sales of EUR 46.9 m (previous year: EUR 46.0 m), thus 2.0 % more than in the previous year. Earnings before interest, taxes, depreciation and amortization (EBITDA) amount to EUR 4.7 m (previous year: EUR 5.3 m). Operating profit (EBIT) adds up to EUR 2.6 m (previous year: EUR 3.3 m). Earnings per share, influenced by currency losses in Japanese Yen, amounts to EUR 0.05 (previous year: EUR 0.34)
This information is based on preliminary financial figures. The Company is set to announce the complete figures for the second quarter and for the first six months of financial year 2012/2013 on May 8, 2013.